Skip to main content
OpenTrials

Clinical trial condition

Raynaud's Phenomenon Secondary to Systemic Sclerosis

Explore clinical trials studying Raynaud's Phenomenon Secondary to Systemic Sclerosis. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Raynaud's Phenomenon Secondary to Systemic Sclerosis trial results

Completed

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

NCT04040322

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +10 more
Locations
  • Arizona Arthritis & Rheumatology Research, PLLC Phoenix, Arizona, United States
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona - Arthritis Research Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 30 locations
View Trial Details
Completed

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

NCT02228850

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +11 more
Locations
  • Diagnamics, Inc. Encinitas, California, United States
  • University of Michigan Scleroderma Program - Division of Rheumatology/Dept. of Internal Medicine Ann Arbor, Michigan, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Scleroderma Research Center - University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions